PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AFAR Vincent Cristofalo Rising Star Award Ceremony to honor Daniel W. Belsky, Ph.D.

Columbia University researcher to present lecture on Quantification of Biological Aging at 53rd Annual AGE Meeting on May 12

2025-05-05
(Press-News.org)

New York, NY and Anchorage, AK — On May 12, 2025, at the 53rd Annual Meeting of the American Aging Association (AGE) in Anchorage, Alaska, the American Federation for Aging Research (AFAR) will host an award ceremony to present the 2025 Vincent Cristofalo Rising Star Award in Aging Research to Daniel W. Belsky, PhD. The event will be held from 1-2pm AKDT in the Tikahtnu Ballroom of the Dena'ina Civic and Convention Center. The award will be presented by AFAR Scientific Director Steven N. Austad, PhD. 

The Vincent Cristofalo Rising Star Award in Aging Research is named in honor of the late Dr. Cristofalo, who dedicated his career to aging research and encouraged young scientists to investigate important issues in the biology of aging. Established in 2008, the award is a framed citation and carries a cash prize of $5,000. 

Daniel W. Belsky, PhD, is an Associate Professor of Epidemiology in the Mailman School of Public Health (Department of Epidemiology and Robert N. Butler Columbia Aging Center) at Columbia University Irving Medical Center (CUIMC). Sitting at the intersection of public health, population and behavioral science, and genomics, the Belsky Lab's research aims to bring breakthroughs from aging biology into public health with the goal of increasing healthy lifespan for all. He is recognized for advancing the development of biomarkers in aging He is recognized for advancing the development of biomarkers in aging. 

Upon accepting AFAR's Cristofalo Award at the May 12th event, Dr. Belsky will share a lecture on the quantification of biological aging. He notes: "The critical challenge in translational geroscience is the need for biomarkers we can measure in the short term that are able to forecast long-term impacts of intervention on healthspan and lifespan. Our contributions to this effort include the development of molecular speedometers – single-timepoint biomarkers that measure the rate at which a person is aging; the focusing of biomarker validation on healthspan rather than lifespan; and the testing of aging biomarkers in clinical trials of candidate geroprotective therapies."

Named after individuals whose dedication and discoveries have made incomparable contributions to field of aging research and have inspired generations of investigators, AFAR's annual AFAR Scientific Awards of Distinction also include the George M. Martin Lifetime Achievement in Mentoring Award, the Irving S. Wright Award of Distinction, and the Terrie Fox Wetle Rising Star Award in Health Services and Aging Research. The awards are nominated by peers and selected by a panel of leading aging researchers. Learn more about past honorees here.

For more insights from Dr. Belsky, read AFAR's Ask the Expert Interview here.

For more information and to register for the AGE Meeting, visit www.americanagingassociation.org/annual-meeting.

 

 

###

About AFAR - The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the field’s talent incubator, providing $212,500,000 to 4,460 investigators at premier research institutions to date—and growing. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and inter-disciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delay—or even prevent—many chronic diseases, often at the same time. They are discovering that it is never too late—or too early—to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of life—at any age. Learn more at www.afar.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

ED visits for asthma spiked during 2023 Canadian wildfires

2025-05-05
New research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241506 found an increase in asthma-related emergency department (ED) visits across Ontario following heavy smoke in early June 2023. Canada experienced the most destructive wildfire season to date in 2023, with difficult-to-control fires across the country, including 29 mega-fires. One fire in Quebec, the province’s largest-ever wildfire, extended 1.2 million acres. Smoke from fires blanketed Canada and the United States, causing substantial damage, loss, and displacement. “The ...

Making virtual reality more accessible

2025-05-05
A team of researchers from the University of Waterloo have created a method that makes virtual reality (VR) more accessible to people with mobility limitations.  VR games like Beat Saber and Space Pirate Trainer usually require large and dramatic movements, such as raising one’s arms above the head or quickly side-stepping, which can be difficult or impossible for people who use wheelchairs or have limited mobility. To decrease these barriers, the researchers created MotionBlocks, a tool that lets users customize ...

AAAS CEO testifies in Senate hearing on biomedical innovation

2025-05-05
AAAS CEO, Sudip S. Parikh, testified as a bipartisan witness before the Senate Appropriations Committee Wednesday, April 30, for a hearing discussing biomedical research in America. Dr. Parikh was joined by three other executives and one patient advocate to express the importance of American support and funding for biomedical research. In Dr. Parikh’s written testimony, he cites the biomedical research ecosystem developed in the United States as the “greatest engine for discovery in the service of health that the world has ever known,” while ...

Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk patients

2025-05-04
Vienna, Austria – Endometrial cancer is the most common gynecological cancer in high-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.* For women with high-intermediate risk disease, adjuvant radiotherapy — particularly vaginal brachytherapy (a form of internal radiotherapy delivered directly to the vaginal area) — is commonly used after surgery to reduce the risk of recurrence. However, patients don’t need it equally, and some may receive more treatment than necessary, exposing ...

New radiotherapy technique aims to protect the heart during lung cancer treatment

2025-05-04
Learning from Every Patient: New Radiotherapy Technique Aims to Protect the Heart During Lung Cancer Treatment Vienna, Austria – A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. Traditional clinical trials are often lengthy and are not representative of real-world patient populations due to complex consent processes and strict eligibility criteria. In contrast, RAPID-RT offers a more inclusive, real-world alternative. Researchers at The Christie NHS Foundation Trust in Manchester, UK, have applied this method in lung cancer patients to assess ...

Five major advances in anal and rectal cancer treatment with radiotherapy

2025-05-03
Vienna, Austria – Rectal cancer is a type of bowel cancer that develops in the last several centimetres of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 people diagnosed annually*. Treatment traditionally involves surgery to remove the tumour—a major operation that can permanently affect sexual function, continence, and quality of life.   While radiotherapy and chemotherapy are already used to shrink tumours before surgery, there is growing momentum behind treatment strategies that avoid surgery ...

SCAI announces Srihari S. Naidu, MD, MSCAI, President for 2025–26

2025-05-03
WASHINGTON— The Society for Cardiovascular Angiography & Interventions (SCAI) has announced its new leadership for 2025–26, with Srihari S. Naidu, MD, MSCAI, assuming the role of President during SCAI Scientific Sessions 2025, held May 1–3 in Washington, DC. Dr. Naidu is Professor of Medicine at New York Medical College and System Director of the Cardiac Catheterization Laboratories and Hypertrophic Cardiomyopathy (HCM) National Center of Excellence at Westchester Medical Center in Valhalla, NY. A leading interventional cardiologist, he is internationally recognized for his work in hypertrophic cardiomyopathy and ...

Turning point in stomach cancer: Early-stage diagnoses now more common

2025-05-03
SAN DIEGO, CA. (MAY 3, 2025) Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages — a shift that marks major progress in detecting one of the deadliest forms of cancer, according to a study to be presented today at Digestive Disease Week® (DDW) 2025. “These trends suggest that advancements in endoscopic imaging, along with more widespread use of upper endoscopy, may be helping doctors find stomach cancer earlier,” said Mohamed Tausif Siddiqui, MD, the study’s ...

Anal cancer rates rising most among older, white and Hispanic women

2025-05-03
SAN DIEGO, CA. (MAY 3, 2025) — Anal cancer has been steadily increasing in the United States, with the biggest jumps among older women, especially white and Hispanic women — a shift that challenges assumptions about high-risk groups and who should be screened, according to a study to be presented today at Digestive Disease Week® (DDW) 2025. “Rates of anal cancer are rising fastest among white and Hispanic women over 65 — groups not traditionally considered high risk,” said lead author Ashley Robinson, MD, a second-year internal medicine resident at Advocate Lutheran General Hospital. “While the exact reasons behind ...

Scientists fight Alzheimer’s by helping glial cells process glucose

2025-05-03
Tokyo, Japan – Researchers from Tokyo Metropolitan University have discovered that impaired glucose metabolism in glial cells, a type of cell in our nervous system, plays a key role in the degeneration caused by Alzheimer’s disease. Using fruit fly retinas, they showed that promoting glucose metabolism in glial cells with tau protein build-up, like in Alzheimer’s patients, helps relieve inflammation and photoreceptor degeneration. Their findings present an exciting new therapeutic target for treating neurodegenerative conditions.   Alzheimer’s ...

LAST 30 PRESS RELEASES:

Bubbles are key to new surface coating method for lightweight magnesium alloys

Carbon stable isotope values yield different dietary associations with added sugars in children compared to adults

Scientists discover 230 new giant viruses that shape ocean life and health

Hurricanes create powerful changes deep in the ocean, study reveals

Genetic link found between iron deficiency and Crohn’s disease

Biologists target lifecycle of deadly parasite

nTIDE June 2025 Jobs Report: Employment of people with disabilities holds steady in the face of uncertainty

Throughput computing enables astronomers to use AI to decode iconic black holes

Why some kids respond better to myopia lenses? Genes might hold the answer

Kelp forest collapse alters food web and energy dynamics in the Gulf of Maine

Improving T cell responses to vaccines

Nurses speak out: fixing care for disadvantaged patients

Fecal transplants: Promising treatment or potential health risk?

US workers’ self-reported mental health outcomes by industry and occupation

Support for care economy policies by political affiliation and caregiving responsibilities

Mailed self-collection HPV tests boost cervical cancer screening rates

AMS announces 1,000 broadcast meteorologists certified

Many Americans unaware high blood pressure usually has no noticeable symptoms

IEEE study describes polymer waveguides for reliable, high-capacity optical communication

Motor protein myosin XI is crucial for active boron uptake in plants

Ultra-selective aptamers give viruses a taste of their own medicine

How the brain distinguishes between ambiguous hypotheses

New AI reimagines infectious disease forecasting

Scientific community urges greater action against the silent rise of liver diseases

Tiny but mighty: sophisticated next-gen transistors hold great promise

World's first practical surface-emitting laser for optical fiber communications developed: advancing miniaturization, energy efficiency, and cost reduction of light sources

Statins may reduce risk of death by 39% for patients with life-threatening sepsis

Paradigm shift: Chinese scientists transform "dispensable" spleen into universal regenerative hub

Medieval murder: Records suggest vengeful noblewoman had priest assassinated in 688-year-old cold case

Desert dust forming air pollution, new study reveals

[Press-News.org] AFAR Vincent Cristofalo Rising Star Award Ceremony to honor Daniel W. Belsky, Ph.D.
Columbia University researcher to present lecture on Quantification of Biological Aging at 53rd Annual AGE Meeting on May 12